SAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- Evofem
Biosciences, Inc., (NASDAQ: EVFM) today announced that Chief
Executive Officer Saundra Pelletier
will present and host one-on-one meetings at the 14th
annual LD Micro Main Event being held in Los Angeles on October
12-14, 2021.
Date:
|
Tuesday, October 12,
2021
|
Time:
|
12:30 p.m. PT (3:30
p.m. ET)
|
Location:
|
Luxe Sunset Bel Air
(Los Angeles), Track 1
|
Evofem recently launched its new direct-to-consumer campaign
"House Rules" focused on building awareness of its hormone-free
contraceptive, Phexxi® (lactic acid, citric acid and potassium
bitartrate), while empowering women to kiss hormonal contraception
goodbye.
The campaign, which launched September 9,
2021, has garnered significant media coverage and is driving
increased site sessions and telehealth visits on Phexxi.com and
Phexxi prescription growth.
Register to watch the virtual presentation at
https://me21.mysequire.com/ or through the Investors section
of the company's website, under "Events & Presentations."
About Evofem Biosciences
Evofem Biosciences, Inc.,
(NASDAQ: EVFM) is developing and commercializing
innovative products to address unmet needs in women's sexual
and reproductive health, including hormone-free, woman-controlled
contraception and protection from certain sexually transmitted
infections (chlamydia and gonorrhea). The Company's first
FDA-approved product, Phexxi, is a hormone-free,
on-demand prescription contraceptive vaginal gel. It comes in a box
of 12 pre-filled applicators and is applied 0-60 minutes before
each act of sex. Learn more at phexxi.com and
evofem.com.
Phexxi® is a registered trademark of Evofem
Biosciences, Inc.
Investor Relations Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
Mobile: (917) 673-5775
View original content to download
multimedia:https://www.prnewswire.com/news-releases/evofem-biosciences-to-present-at-ld-micro-investor-conference-on-october-12-2021-301388698.html
SOURCE Evofem Biosciences, Inc.